Biventricular vs. right ventricular pacing devices in patients anticipated to require frequent ventricular pacing (BioPace)
Europace · 05.03.2025 · 27 (3)
DOI: 10.1093/europace/euaf029 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Europace, online erschienen am 19.03.2025. Verfasst von Reinhard C Funck und 10 weiteren Autor:innen. Beteiligte Einrichtung: Klinik für Innere Medizin - Kardiologie, Philipps-Universität Marburg, Baldingerstr, Marburg 35033, Germany. Hauptthemen laut MEDLINE: Cardiac Resynchronization Therapy, Atrioventricular Block, Cardiac Resynchronization Therapy Devices, Heart Failure. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abbott.
Abstract (Originalsprache)
Aims
Right ventricular (RV) pacing may promote left ventricular (LV) dysfunction. Particularly in patients with preserved LV ejection fraction (LVEF), narrow QRS, and anticipated high ventricular pacing burden (HVPB), evidence is missing that biventricular (BiV) pacing can improve clinical outcome. We therefore evaluated whether implantation of a BiV pacing device (BiVPD) compared with a RV pacing device (RVPD) may improve clinical outcome in predominantly this kind of patients. Methods and results In the Biventricular Pacing for atrioventricular Block to Prevent Cardiac Desynchronization (BioPace) trial [multicentre, single-blinded (patients), randomized, parallel group], patients were equally allocated to either receive a BiVPD or a RVPD. Co-primary endpoints were (i) the composite of time to death or first heart failure hospitalization and (ii) survival time. We analysed 1810 randomized patients (median age: 73.5 years; female sex: 31.7%; mean LVEF 55.4%; mean QRS 118.4 ms), 902 to BiV and 908 to RV pacing. During mean follow-up of 68.8 months, the difference in the primary composite endpoint between both groups [346 vs. 363 events, hazard ratio (HR) 0.878; 95% confidence interval (CI) 0.756–1.020; P = 0.0882) or in mortality (305 vs. 307 deaths, HR 0.926; 95% CI 0.789-1.088; P = 0.3492) was smaller than 20%.
Conclusion
In patients, predominantly with preserved LVEF, narrow QRS, and HVPB, superiority of implanting BiVPDs compared with RVPDs could not be proven. Right ventricular pacing may be less harmful for this kind of patients than often suggested and primary BiV pacing does not clearly improve their clinical outcome. Clinical trial registration Registered in ClinicalTrials.gov, number NCT00187278 (https://clinicaltrials.gov/ct2/show/study/NCT00187278).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Klinik für Innere Medizin - Kardiologie, Philipps-Universität Marburg, Baldingerstr, Marburg 35033, Germany.
- Institut für Medizinische Bioinformatik und Biostatistik, Philipps-Universität Marburg, Hans-Meerwein-Str. 6, Marburg 35043, Germany.
- Cardiologia 3 - Elettrofisiologia, Ospedale Niguarda, Piazza Ospedale Maggiore 3, Milano 20162, Italy.
- Cardiology Department, CHU Namur, Ave G. Therasse 1-8, Yvoir 5530, Belgium.
- Department of Cardiology, Klinikum St. Georg gGmbH, Delitzscher Str. 141, Leipzig 04129, Germany.
- Praxisklinik HerzKreislauf am WASA-Platz, August-Bebel-Str. 33, Dresden 01219, Germany.
ORCID-Profile: Reinhard C Funck, Hans-Helge Müller, Norbert Klein, Eckhard Meisel, Goran Milasinovic, Mark D Carlson, Michael Wittenberg, Gerhard Hindricks
Förderung
- Abbott
Zitieren
APA
Funck, R. C., Müller, H. H., Lunati, M., De Roy, L., Klein, N., Meisel, E., Milasinovic, G., Carlson, M. D., Wittenberg, M., Hindricks, G., & Blanc, J. J. (2025). Biventricular vs. right ventricular pacing devices in patients anticipated to require frequent ventricular pacing (BioPace). Europace, 27(3). https://doi.org/10.1093/europace/euaf029
Vancouver
Funck RC, Müller HH, Lunati M, De Roy L, Klein N, Meisel E, et al. Biventricular vs. right ventricular pacing devices in patients anticipated to require frequent ventricular pacing (BioPace). Europace. 2025;27(3). doi:10.1093/europace/euaf029
BibTeX
@article{Funck2025,
author = {Funck, Reinhard C and Müller, Hans-Helge and Lunati, Maurizio and De Roy, Luc and Klein, Norbert and Meisel, Eckhard and Milasinovic, Goran and Carlson, Mark D and Wittenberg, Michael and Hindricks, Gerhard and Blanc, Jean-Jacques},
title = {Biventricular vs. right ventricular pacing devices in patients anticipated to require frequent ventricular pacing (BioPace)},
journal = {Europace},
year = {2025},
volume = {27},
number = {3},
doi = {10.1093/europace/euaf029}
}
EUVIMED